Austral Capital Partners

Fiscalía Privada is a legal services platform focused on protecting companies from criminal activities and managing operational losses. Through innovative solutions, it provides a comprehensive security experience that emphasizes prevention and deterrence. The company specializes in investigating and prosecuting crimes against businesses, including robberies, thefts, scams, and forgeries. By offering legal assistance, Fiscalía Privada aims to ensure justice for its clients and facilitate the swift and efficient development of their business operations.

Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.

Scopix is a leader in intelligent video analytics tailored for retailers, consumer packaged goods companies, and manufacturers. The company offers a cloud-based platform that delivers actionable insights through its Real.Suite™ family of solutions. This platform collects data on key performance indicators such as store personnel effectiveness, customer feedback, and queue lengths, which are essential for enhancing retail operations. By providing timely information via a web-based portal, Scopix enables store personnel, regional managers, and corporate executives to optimize the customer experience and improve overall business performance, ultimately driving sales and maximizing profits.

Scopix is a leader in intelligent video analytics tailored for retailers, consumer packaged goods companies, and manufacturers. The company offers a cloud-based platform that delivers actionable insights through its Real.Suite™ family of solutions. This platform collects data on key performance indicators such as store personnel effectiveness, customer feedback, and queue lengths, which are essential for enhancing retail operations. By providing timely information via a web-based portal, Scopix enables store personnel, regional managers, and corporate executives to optimize the customer experience and improve overall business performance, ultimately driving sales and maximizing profits.

Junar, Inc. operates a cloud-based open data platform that facilitates the accessibility of data for organizations globally, including businesses, governments, NGOs, and academic institutions. Founded in 2006 and headquartered in Palo Alto, California, Junar's platform allows users to identify, organize, and optimize data while transforming it into engaging visual formats such as tables, charts, and maps. The platform also includes an API toolbox that enables developers to create innovative applications for data presentation. By empowering organizations to publish their data, Junar fosters new opportunities, enhances collaboration, and promotes transparency. With additional offices in Dallas, Silicon Valley, Latin America, and Israel, the company has established itself as a trusted partner for managing and leveraging valuable data assets.

Nimbic is a provider of cloud-based electronic design automation (EDA) solutions specializing in electromagnetic integrity for the microelectronics industry. Headquartered in Mountain View, California, the company offers services that address challenges related to signal integrity, power integrity, and electromagnetic interference across various design domains, including microprocessors, FPGAs, memory, wireless RF systems, and high-speed channels. Nimbic's nCloud solution enables efficient chip-package-system co-design, significantly reducing time-to-market and costs for its clients. The company's advanced technology delivers high-capacity, rapid 3D simulations throughout the entire design cycle, maintaining exceptional accuracy and performance. Nimbic serves a global clientele that includes notable companies such as Texas Instruments, Renesas, Toshiba, Tabula, and Panasonic.

Nimbic is a provider of cloud-based electronic design automation (EDA) solutions specializing in electromagnetic integrity for the microelectronics industry. Headquartered in Mountain View, California, the company offers services that address challenges related to signal integrity, power integrity, and electromagnetic interference across various design domains, including microprocessors, FPGAs, memory, wireless RF systems, and high-speed channels. Nimbic's nCloud solution enables efficient chip-package-system co-design, significantly reducing time-to-market and costs for its clients. The company's advanced technology delivers high-capacity, rapid 3D simulations throughout the entire design cycle, maintaining exceptional accuracy and performance. Nimbic serves a global clientele that includes notable companies such as Texas Instruments, Renesas, Toshiba, Tabula, and Panasonic.

Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.

Andes Biotechnologies S.A. is a biotechnology company based in Santiago, Chile, focused on the research, development, and marketing of innovative anti-cancer therapies in the United States and Europe. Founded in 2010, the company specializes in nucleic acid-based drug discovery, particularly targeting solid tumor cancers. It has developed proprietary technology utilizing long non-coding RNAs, specifically sense (S-RNA) and antisense (AS-RNA), which are synthesized in mitochondria and migrate to the nucleus. These oligonucleotide drugs selectively induce apoptosis in cancer cells, leaving normal cells unharmed. Andes Biotechnologies is currently advancing its lead drug, Andes-1537, through clinical development and holds an active investigational new drug (IND) application in the United States. The company is supported by an experienced management team and a strong network of collaborators in the cancer research field, along with a comprehensive intellectual property portfolio.

Bio Architecture Lab is a pioneer in the application of synthetic biology and enzyme design to the development of biofuels and renewable chemicals from aquafarmed, native macroalgae (seaweed), which is a low cost, scalable, and sustainable biomass.

Atakama Labs is a developer, publisher, and operator of social games, with a focus on creating meaningful gaming experiences that entertain and positively impact players' lives. The company primarily develops its games in Chile and distributes them globally, utilizing both direct publishing and partnerships based on platform and territory. Atakama Labs emphasizes accessibility by offering their games for free, allowing a broad audience to engage with their content. The company is supported by venture capital funds, including Austral Capital and the COPEC-UC Fund.

Paperless is a company based in Latin America that specializes in electronic receipts and document management services. It processes over two billion documents annually for global enterprise clients. The company provides a range of services, including the creation, processing, management, and custody of electronic documents such as invoices, ballots, and contracts. By enabling standardized and large-scale document handling, Paperless helps businesses efficiently store and manage their data in a digital format.

Scanntech is a company based in Montevideo, Uruguay, that provides point-of-sale software and retail analytics solutions tailored for supermarket retailers and fast-moving consumer goods (FMCG) suppliers. Founded in 1992, Scanntech's technology enables independent supermarkets to effectively manage transactions, inventory, and financial services through its advanced point-of-sale systems. The platform also offers features such as ticket waiting functions, reporting capabilities, and various payment options, all designed to enhance the overall sales process. By leveraging these solutions, Scanntech aims to improve both the volume and quality of sales for its clients.